Changes in bilirubin in infants with hypoxic-ischemic encephalopathy
Related Experiment Video
Updated: Feb 5, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Carlo Dani1,2, Chiara Poggi3, Claudia Fancelli3
1Division of Neonatology, Careggi University Hospital of Florence, 3 Largo Brambilla, 50141, Florence, Italy. cdani@unifi.it.
Insights
Total serum bilirubin (TSB) levels were lower in infants with hypoxic-ischemic encephalopathy (HIE) than in controls. Both HIE and therapeutic hypothermia independently decreased TSB, suggesting bilirubin does not offer neuroprotection in HIE.
Area of Science:
- Neonatal Medicine
- Neuroscience
- Biochemistry
Background:
- Oxidative stress is key in hypoxic-ischemic encephalopathy (HIE) pathophysiology.
- Bilirubin possesses antioxidant properties.
- The neuroprotective role of bilirubin in HIE remains unevaluated.
Purpose of the Study:
- To investigate the involvement of bilirubin in neuroprotection against oxidative stress in infants with HIE.
- To determine if total serum bilirubin (TSB) levels increase in infants with HIE.
Main Methods:
- Retrospective study of infants with moderate-to-severe HIE (gestational age ≥35 weeks, birth weight ≥1800 g).
- Comparison of peak and mean TSB values between HIE infants (with or without therapeutic hypothermia) and a control group.
- Regression analysis to identify factors influencing TSB levels.
Main Results:
- Infants with HIE had lower peak and mean TSB values compared to controls.
- Therapeutic hypothermia did not significantly alter TSB levels within the HIE group.
- HIE and hypothermia independently reduced the likelihood of elevated TSB.
Conclusions:
- Lower TSB levels in HIE infants suggest bilirubin is not a neuroprotective factor via TSB increase.
- HIE and hypothermia decrease TSB, potentially due to hypoxic repression of heme oxygenase (HO) expression.
- This decrease may represent a protective mechanism limiting brain injury in HIE.
Abstract:
Antioxidant properties of bilirubin have been reported in many studies. We hypothesized that bilirubin might be involved in neuroprotection mechanisms against oxidative stress in infants with hypoxic-ischemic encephalopathy (HIE) and that total serum bilirubin (TSB) might increase in these patients. We retrospectively studied infants with gestational age ≥ 35 weeks and birth weight ≥ 1800 g who were admitted to the neonatal intensive care unit (NICU) with a diagnosis of moderate-to-severe HIE and received or did not receive therapeutic hypothermia. We evaluated peak TSB and changes of mean TSB in these patients in comparison with a control group of infants admitted to the NICU with diagnoses other than HIE. Peak and mean TSB values were lower in the no hypothermia and hypothermia groups in comparison with the control group, while differences were not noted between infants who received hypothermia or did not. Regression analysis showed that HIE and hypothermia significantly reduced the risk of developing TSB values higher than median value (> 8.4 mg/dL) in our population.Conclusion: Peak and mean TSB values were lower in infants with moderate-to-severe HIE than in control infants. HIE and hypothermia independently decreased TSB. These results exclude a TSB increase as a neuroprotective mechanism in infants with HIE. We speculated that low TSB values in infants with HIE could be due to hypoxic repression of HO expression and represent a defensive strategy for limiting brain injuries in these patients. What is Known: • The role of oxidative stress in the pathophysiology of hypoxic-ischemic encephalopathy (HIE) has been elucidated in many studies, and other studies have demonstrated the antioxidant properties of bilirubin. • The potential neuroprotective role of bilirubin as antioxidant agent has never been evaluated in infants with HIE. What is New: • Mean total serum bilirubin (TSB) values are lower in infants with moderate-to-severe HIE than in control infants, since HIE and hypothermia independently decreased TSB. • An increase in bilirubin was not a neuroprotective mechanism in infants with HIE possibly because of hypoxic repression of HO expression as defensive strategy for limiting brain injuries.
Related Concept Videos
Drug Dosing: Infants and Children
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Accessory Organs
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Theory of Romantic Attachment in Adulthood

